A Phase Ib/II Clinical Study on AK112 Combined or Not Combined With AK119 in pMMR/MSS Colorectal Cancer

NCT05846867 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: AK119
DRUG: AK112
DRUG: Oxaliplatin
DRUG: Irinotecan
DRUG: Calcium folinate
DRUG: Fluorouracil

Sponsor

Akeso